期刊文献+

左卡尼汀联合西地那非对雄性糖尿病大鼠生殖内分泌功能的保护作用 被引量:2

Protective effect of L-carnitine combined with sildenafil on the reproductive endocrine function of diabetic male rats
原文传递
导出
摘要 目的:初步探讨左卡尼汀与西地那非片在保护糖尿病(DM)大鼠生殖内分泌功能中的作用。方法:40只体重为200~230 g的雄性SD大鼠随机均分为5组:A组为正常对照组,B组为DM大鼠模型组,C组为DM大鼠给予西地那非[5 mg/(kg.d)]治疗组,D组为DM大鼠给予左卡尼汀[300 mg/(kg.d)]治疗组,E组为DM大鼠给予左卡尼汀[300 mg/(kg.d)]联合西地那非[5 mg/(kg.d)]治疗组。各组大鼠治疗6周后分别进行血睾酮(T)、卵泡刺激素(FSH)、黄体生成素(LH)的检测。结果:糖尿病大鼠治疗6周后,血清T,FSH、LH含量,A组:T为(25.25±2.67)nmol/L,FSH为(5.78±0.61)IU/L,LH为(625.21±43.45)ng/L;B组:T为(9.63±1.71)nmol/L,FSH为(1.98±0.42)IU/L,LH为(479.89±27.62)ng/L:C组:T为(18.98±3.07)nmol/L,FSH为(5.08±0.33)IU/L,LH为(586.57±31.72)ng/L;D组:T为(16.18±2.65)nmol/L,FSH为(4.63±0.30)IU/L;LH为(540.78±25.52)ng/L;E组:T为(23.65±2.66)nmol/L,FSH为(5.59±0.48)IU/L,LH为(621.53±36.40)ng/L。各组血清T,FSH、LH含量之间比较,B组均显著低于A、C、D、E组(P均<0.01);C、D组均显著低于A、E组(P均<0.05),而C、D组之间比较,差异均无显著性(P>0.05);E组与A组比较,差异也均无显著性(P>0.05)。结论:西地那非片与左卡尼汀灌胃6周后均可增加DM大鼠血清T、FSH、LH的水平,而两者联合用药时,T、FSH、LH增加水平比单独用药更明显,显示联合用药在保护雄性DM大鼠生殖内分泌功能方面效果更佳。 Objective: To investigate the protective effect of L-carnitine(LC) combined with sildenafil on the reproductive endocrine function of male rats with diabetes mellitus(DM).Methods: A total of 40 male SD rats were randomly divided into five groups,group A taken as normal controls,and groups B,C,D and E made into DM models by injection of streptozotocin at 65 mg/kg.Then the rats in groups A and B were treated with normal saline,C with sildenafil at 5 mg per kg per d,D with LC at 300 mg per kg per d,and E with sildenafil at 5 mg per kg per d plus LC at 300 mg per kg per d,all via gastric gavage for 6 weeks,followed by determination of the levels of testosterone(T),follicle-stimulating hormone(FSH) and luteinizing hormone(LH) in the serum of the rats.Results: After 6 weeks of treatment,the T,FSH and LH levels were(25.25±2.67) nmol/L,(5.78±0.61) IU/L and(625.21±43.45) ng/L in group A,(9.63±1.71) nmol/L,(1.98±0.42) IU/L and(479.89±27.62) ng/L in group B,(18.98±3.07) nmol/L,(5.08±0.33) IU/L and(586.57±31.72) ng/L in group C,(16.18±2.65) nmol/L,(4.63±0.30) IU/L and(540.78±25.52) ng/L in group D,and(23.65±2.66) nmol/L,(5.59±0.48) IU/L and(621.53±36.40) ng/L in group E.The three parameters were significantly lower in B than in the other four groups(P〈0.01),and so were they in C and D than in A and E(P〈0.05),but showed no significant differences either between C and D(P〉0.05) or between A and E(P〉0.05).Conclusion: Six-week medication of either sildenafil or LC alone could increase the levels of T,FSH and LH in the serum of DM rats,but the combination of the two had an even more obvious increasing effect,which indicates a still better protective effect on the reproductive endocrine function of diabetic male rats.
出处 《中华男科学杂志》 CAS CSCD 2012年第9期789-792,共4页 National Journal of Andrology
基金 国家自然科学基金(81270739) 2009年度军区医学科技创新课题(09MA008)~~
关键词 糖尿病大鼠 雄性 左卡尼汀 西地那非 生殖激素 diabetic rat,male; L-carnitine; sildenafil; reproductive hormone;
  • 相关文献

参考文献16

  • 1Singh S, Malini T, Rengarajan S, et al. Impact of experimental diabetes and insulin replacement on epididymal secretory products and sperm maturation in albino rats. J Cell Biochem, 2009, 108 (5) : 1094-1101.
  • 2La Vignera S, Condorelli R, Vicari E, et al. Diabetes mellitus and sperm parameters. J Androl, 2012, 33(2) : 145-153.
  • 3Ballester J, Munfiz MC, Domlnguez J, et al. Insulin-dependent diabetes affects testicular function by FSH and LH-linked mecha- nisms. J Androl, 2004, 25(5) : 706-719.
  • 4De Young L, Yu D, Freeman D, et al. Effect of PDE5 inhibition combined with free oxygen radical scavenger therapy on erectile function in a diabetic animal model. Int J Impot Res, 2003, 15 (5) : 347-354.
  • 5Sudha S, Valli G, Julie PM, et al. Influence of streptozotocin- induced diabetes and insulin treatment on the pituitary-testicular axis during sexual maturation in rats. Exp Clin Endocrinol Diabe- tes, 2000, 108(1): 14-20.
  • 6许松,高建平.糖尿病性勃起功能障碍的发病机制及治疗进展[J].中华男科学杂志,2004,10(3):218-221. 被引量:44
  • 7Skrzypulec V, Nowosielski K, Drosdzol A, et al. Sexual dys-functions in selected endocfinopathies. Endokrynol Pol, 2005, 56(6) : 964-969.
  • 8黎英荣,潘海林,苏宏业,邓宏明,肖常青.糖尿病大鼠血清睾丸酮水平的变化及其与勃起功能障碍的相关研究[J].广西医科大学学报,2006,23(2):284-286. 被引量:8
  • 9Kapoor D, Clarke S, Charmer KS, et al. Erectile dysfunction is associated with low bioactive testosterone levels and visceral adi- posity in men with type 2 diabetes. Int J Androl, 2007, 30 (6) : 500-507.
  • 10Schfer A, Fraccarollo D, Pfrtsch S, et al. Improvement of vas- cular function by acute and chronic treatment with the PDE-5 in- hibitor sildenafil in experimental diabetes mellitus. Br J Pharma- col, 2008, 153(5) : 886-893.

二级参考文献41

  • 1Akingba AG, Burnett AL. Endothelial nitric oxide synthase protein expression, localization, and activity in the penis of the alloxan-induced diabetic rat[J]. Mol Urol, 2001, 5(4):189-197.
  • 2Seftel AD, Vaziri ND, Ni Z, et al. Advanced glycation end products in human penis: elevation in diabetic tissue, site of deposition, and possible effect through iNOS or eNOS[J]. Urology, 1997, 50(6):1016-1026.
  • 3Xu B, Chibber R, Ruggerio D, et al. Impairment of vascular endothelial nitric oxide synthase activity by advanced glycation end products[J]. FASEB J, 2003, 17(10):1289-1291.
  • 4Hopfner RL, Gopalakrishnan V. Endothelin: emerging role in diabetic vascular complications[J]. Diabetologia, 1999, 42(12):1383-1394.
  • 5Sullivan ME, Dashwood MR, Thompson CS, et al. Alterations in endothelin B receptor sites in cavernosal tissue of diabetic rabbits: potential relevance to the pathogenesis of erectile dysfunction[J]. J Urol, 1997, 158(5):1966-1972.
  • 6Chang S, Hypolite JA, Changolkar A, et al. Increased contractility of diabetic rabbit corpora smooth muscle in response to endothelin is mediated via Rho-kinase beta[J]. Int J Impot Res, 2003, 15(1):53-62.
  • 7Dinulovic D, Radonjic G. Diabetes mellitus/male infertility[J]. Arch Androl, 1990, 25(3):277-293.
  • 8Alexopoulou O, Jamart J, Maiter D, et al. Erectile dysfunction and lower androgenicity in type 1 diabetic patients[J]. Diabets Metab, 2001, 27(3):329-336.
  • 9Lepore G, Nosari I. Efficacy of oral sildenafil in the treatment of erectile dysfunction in diabetic men with positive response to intracavernosal injection of alprostadil[J]. Diabetes Care, 2001, 24(2):409-411.
  • 10Goldstein I, Young JM, Fischer J, et al. Vardenafil, a new phosphodiesterase type 5 inhibitor, in the treatment of erectile dysfunction in men with diabetes: a multicenter double-blind placebo-controlled fixed-dose study[J]. Diabetes Care, 2003, 26(3):777-783.

共引文献50

同被引文献25

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部